uniQure NV
QURE
19.35
-0.88
-4.35%
uniQure NV
US · QURE
#2954 by market cap
Listed 1970
19.35
-0.88
-4.35%
Periodic snapshot; not a real-time feed.
· 2026-11-20 20:02
✦ Quant Ownership Signal how this is computed
Distributing
- The number of reporting institutions decreased by 12 in the most recent period (2026/Q3).
- Total institutional ownership (as a % of shares) was little changed.
Ownership vs. money flow
AlignedInstitutions trimmed shares last reporting period, and the stock has seen net outflows in main-fund flow over the last 20 trading sessions - the two line up.
Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.
Institutional ownership
- Held by institutions
- 97.73% -0.03pp
- Institutions
- 296 -12
- As of
- 2026/Q3 vs. prior period
Holder types
Hedge Fund41.61%
Mutual Fund38.35%
Public Company7.09%
VC/PE Fund5.76%
Private Company4.05%
Individual/Insider1.68%
Government Pension Fund0.52%
Family Office/Trust0.26%
Insurance Company0.11%
Other0.59%
Top holders as of 2026-06-30
Avoro Capital Advisors LLC
9.59% · 6.73M sh
J.P. Morgan Asset Management, Inc.
6.74% · 4.73M sh
RTW Investments, LP
5.62% · 3.94M sh
State Street Global Advisors
3.68% · 2.58M sh
BlackRock
3.01% · 2.11M sh
Morgan Stanley Investment Management Inc.
2.76% · 1.93M sh
Morgan Stanley
2.76% · 1.93M sh
abrdn plc
2.73% · 1.92M sh
Jane Street Group, LLC
2.32% · 1.61M sh
OrbiMed Advisors LLC
2.58% · 1.81M sh
Jennison Associates LLC
2.23% · 1.56M sh
Boxer Capital Management, LLC
2.17% · 1.50M sh
Bar length is relative to the largest holder shown here, not to 100% of the company.
Insiders
50 filings tracked · 18 buys · 32 sells
| Name | Role | Stake |
|---|---|---|
| Matthew Kapusta | Chief Executive Officer | 0.74% |
| Walid Abi-Saab | Chief Medical Officer | 0.24% |
| Christian Klemt | CFO, Principal Financial Officer & GM of Amsterdam Site | 0.17% |
| Kylie O'Keefe | Chief Customer & Strategy Officer | 0.16% |
| Jeannette Potts | Chief Legal & Compliance Officer and Corporate Secretary | 0.08% |
| Madhavan Balachandran | Independent Non-Executive Director | 0.06% |
| Jeremy Springhorn | Independent Non-Executive Director | 0.05% |
| David Meek | Independent Chairperson | 0.05% |
| Leonard Post | Independent Non-Executive Director | 0.04% |
| Rachelle Jacques | Non-Executive Director | 0.04% |
| Jack Kaye | Independent Non-Executive Director | 0.04% |
Insider transactions most recent Form 4 filings
| Date | Name | Role | Type | Shares | Price |
|---|---|---|---|---|---|
| 2026-11-05 | David Meek | Independent Chairperson | Open Market Disposition | -9,080 | $21.25 |
| 2026-10-29 | Walid Abi-Saab | Chief Medical Officer | Other Acquisition | +18,750 | -- |
| 2026-07-01 | Matthew Kapusta | Chief Executive Officer | Derivative Exercise and Sale | -21,082 | $19.39–45.89 |
| 2026-06-29 | Jack Kaye | Independent Non-Executive Director | Derivative Exercise and Sale | -21,167 | $20.18–46.49 |
| 2026-06-29 | Walid Abi-Saab | Chief Medical Officer | Automatic Disposition | -20,000 | $46.40 |
| 2026-06-29 | Walid Abi-Saab | Chief Medical Officer | Derivative Exercise and Sale | -10,000 | $5.59–46.46 |
| 2026-06-25 | Walid Abi-Saab | Chief Medical Officer | Open Market Disposition | -1,434 | $46.86 |
| 2026-06-24 | Matthew Kapusta | Chief Executive Officer | Derivative Exercise and Sale | -32,844 | $31.71–50.02 |
| 2026-06-24 | Matthew Kapusta | Chief Executive Officer | Intent to Sell (Form 144) | -28,716 | $50.02 |
| 2026-06-23 | Matthew Kapusta | Chief Executive Officer | Automatic Disposition | -2,568 | $50.00 |
| 2026-06-17 | Matthew Kapusta | Chief Executive Officer | Automatic Disposition | -138,863 | $43.43–50.00 |
| 2026-06-17 | Matthew Kapusta | Chief Executive Officer | Derivative Exercise and Sale | -67,237 | $19.39–50.00 |
| 2026-06-17 | Matthew Kapusta | Chief Executive Officer | Intent to Sell (Form 144) | -41,671 | $46.38 |
| 2026-06-16 | Matthew Kapusta | Chief Executive Officer | Intent to Sell (Form 144) | -164,429 | $43.00 |
| 2026-06-16 | Jack Kaye | Independent Non-Executive Director | Derivative Exercise and Sale | -5,295 | $31.71–42.57 |
| 2026-06-16 | Madhavan Balachandran | Independent Non-Executive Director | Derivative Exercise and Sale | -11,685 | $19.39–47.08 |
| 2026-06-14 | Madhavan Balachandran | Independent Non-Executive Director | Derivative Exercise and Sale | -10,000 | $8.49–27.85 |
| 2026-06-14 | Jeannette Potts | Chief Legal & Compliance Officer and Corporate Secretary | Open Market Disposition | -5,237 | $27.67 |
| 2026-06-10 | Leonard Post | Independent Non-Executive Director | Open Market Disposition | -1,993 | $27.06 |
| 2026-06-10 | Jack Kaye | Independent Non-Executive Director | Open Market Disposition | -1,993 | $27.06 |
Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.
Quote time 2026-11-20 20:02:37 · For reference only, not investment advice and not tailored to your situation.
uniQure NV discussion 0 comments